Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Mindfulness Based Childbirth and Parenting Education - RCT of Effects on Parent and Child Health (MBCP)

7 août 2018 mis à jour par: Gunilla Lönnberg, Karolinska Institutet
The purpose of this study is to explore if an intervention using Mindfulness Based Childbirth and Parenting education (MBCP) targeted to stressed pregnant women is effective in: 1) reducing prenatal stress, 2) preventing perinatal maternal mental ill-health, 3) preparing the mother for labor and 4) promoting positive infant-caregiver attachment.

Aperçu de l'étude

Description détaillée

Sample: Pregnant women experiencing high levels of stress, and/or who previously have had periods of depression or anxiety, and/or who have had some childhood neglect, will be eligible for the study. A sample of 170 mothers and their partners recruited from antenatal clinics in Stockholm will be asked to participate. The participants in the study will be randomized to either treatment or control intervention. The study uses an experimental design with assessments at baseline and post-intervention as well as follow-ups at 3, 9 and 15 months post-partum. The intervention involves eight 2.5 h weekly group sessions in which exercises in mindfulness are practiced and associated theory is taught to increase metacognition, emotional regulation and body awareness. Participants in the control condition are being offered a standardized course in psychoprophylaxis.

Measurements - parental outcomes PSYCHOLOGICAL FUNCTIONING - 10 item Perceived Stress Scale [10]. Edinburgh Postnatal Depression Scale [11]. Positive States of Minds [12].

INTERVENTION ADHERENCE - Questions to assess intervention adherence. PHYSIOLOGICAL ASSESSMENTS - Heart Rate Variability (HRV) will be examined through ECG. The investigators hypothesize that the intervention will increase HRV in the pregnant women, thus providing an objective measure of stress. The investigators will test if women who receive the intervention during pregnancy have lower serum levels of the cytokines interleukin-6 and interleukin-10, Brain Derived Neurotrophic Factor-s, and Corticotrophin Releasing Hormone compared to the control group - physiological components that influence the fetus and are associated with immune response, hypothalamic-pituitary-adrenal axis functions, stress-related mood disorders and preterm delivery [13-16].

LABOUR - Labour records will be gathered from all participants.

Measurements - infants PHYSIOLOGICAL ASSESSMENTS - Heart Rate Variability (HRV) examined through ECG at 15 months of age. The investigators hypothesize that increased maternal HRV in the pregnancy will be associated with increased infant HRV. The investigators will also test if infants whose mothers have received the intervention have lower serum levels of the cytokines interleukin-6 and interleukin-10, Brain Derived Neurotrophic Factor-S, and Corticotrophin Releasing Hor-mone: Levels will be analyzed from PKU blood spots, routinely collected 3-4 days after birth.

INFANT SOCIAL AND EMOTIONAL FUNCTIONING - The attachment style of the infants will be assessed at age 15 months, using the standard Parent-Child Early Relational Assessment developed by Clark [17].

Data analysis: Appropriate methods will be applied to describe the sample. Hypothesis will be tested by multivariate repeated measures analysis of covariance (MANCOVA) with perceived stress as the primary outcome.

Type d'étude

Interventionnel

Inscription (Réel)

193

Phase

  • N'est pas applicable

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Femelle

La description

Inclusion Criteria:

The study is open to pregnant women in the late second or early third trimester of pregnancy who are screened with a short questionnaire: Those who report high levels of perceived stress, and/or previous mental health issues such as depression/anxiety, and/or childhood neglect are included. Participants must also speak fluent Swedish.

Exclusion Criteria: Actively psychotic, having previous experience of mindfulness, third wave cognitive behavioral therapies, or related practices.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: MBCP intervention
The intervention involves eight 2.5 h weekly group sessions in which exercises in mindfulness are practiced and associated theory is taught to increase metacognition, emotional regulation and body awareness.
Eight weekly sessions 2,5 h and homework 30 min/day. Practicing various mindfulness meditations coupled with practical skills and theory of birthing and parenting.
Comparateur actif: Control condition
Participants in the control condition are being offered a standardized course in psychoprophylaxis.
Three sessions 3h each, and practices to do at home. Practical skills of relaxation and breathing techniques for labor as well as knowledge of birthing and parenting.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Change in Perceived Stress Scale 14-item
Délai: From baseline to 9 weeks (postintervention) and follow-ups when infant is 3, 9 and 12 months old
A scale measuring perception of stressful experiences during the past month
From baseline to 9 weeks (postintervention) and follow-ups when infant is 3, 9 and 12 months old
Parent Child Early Relational Assessment
Délai: When infant is 12 months old
Measures infant and primary caregiver attachment
When infant is 12 months old

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Change in Maternal heart rate variability
Délai: from baseline to 9 weeks (post-intervention)
Examined through ECG
from baseline to 9 weeks (post-intervention)
Change in Maternal serum levels of cytokines interleukin-6 and interleukin-10
Délai: from baseline to 9 weeks (post-intervention)
from baseline to 9 weeks (post-intervention)
Change in Maternal serum levels of Brain Derived Neurotrophic Factor-s
Délai: from baseline to 9 weeks (post-intervention)
from baseline to 9 weeks (post-intervention)
Change in Maternal serum levels of Corticotrophin Releasing Hormone
Délai: from baseline to 9 weeks (post-intervention)
from baseline to 9 weeks (post-intervention)
Change in Edinburgh Postnatal Depression Scale
Délai: From baseline to 9 weeks (postintervention) and follow-ups when infant is 3, 9 and 12 months old
A 10-item scale measuring anxiety and depression
From baseline to 9 weeks (postintervention) and follow-ups when infant is 3, 9 and 12 months old
Change in Positive States of Minds
Délai: From baseline to 9 weeks (postintervention) and follow-ups when infant is 3, 9 and 12 months old
A six-item scale measuring different positive emotional and cognitive experiences
From baseline to 9 weeks (postintervention) and follow-ups when infant is 3, 9 and 12 months old
Change in Five Facets of Mindfulness
Délai: From baseline to 9 weeks (postintervention) and follow-ups when infant is 3, 9 and 12 months old
29-item scale measuring mindfulness
From baseline to 9 weeks (postintervention) and follow-ups when infant is 3, 9 and 12 months old
Labour records
Délai: 1 week after giving birth
Labour records will be assessed as regards to labour complications and use of pain relief and labour induction
1 week after giving birth
Infant serum levels of the cytokines interleukin-6 and interleukin-10
Délai: At age 2-3 days
Levels will be analyzed from dried PKU blood spots
At age 2-3 days
Infant serum levels of Brain Derived Neurotrophic Factor-S
Délai: At age 2-3 days
Levels will be analyzed from dried PKU blood spots
At age 2-3 days
Infant serum levels of Corticotrophin Releasing Hormone
Délai: At age 2-3 days
Levels will be analyzed from dried PKU blood spots
At age 2-3 days
Infant Heart Rate Variability
Délai: At age 12 months
Examined through ECG
At age 12 months
Pregnancy Interveiw
Délai: Baseline measure
Developed by Prof. Arietta Slade an interview concerning attachment to the expected child and the parents.
Baseline measure

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Qualitative study of perceived experience of MBCP-intervention
Délai: When participants infant is 3-4 months old
Individual in-depth interviews regarding the participants experiences of MBCP
When participants infant is 3-4 months old

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Eva Nissen, Professor, Karolinska Institutet

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 janvier 2015

Achèvement primaire (Réel)

1 janvier 2017

Achèvement de l'étude (Réel)

1 août 2018

Dates d'inscription aux études

Première soumission

4 mai 2015

Première soumission répondant aux critères de contrôle qualité

7 mai 2015

Première publication (Estimation)

12 mai 2015

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

8 août 2018

Dernière mise à jour soumise répondant aux critères de contrôle qualité

7 août 2018

Dernière vérification

1 août 2018

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

INDÉCIS

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner